Showing results (1241-1250 of 4,506) with videos related to
Sort By:
Pageof 451
Advances in Therapy|August 31, 2023
Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk FactorsJaewon Oh, Wonho Kim, Gee-Hee Kim, et al.Advances in Therapy|September 13, 2023
Incidence of Hypophosphatemia After Intravenous Administration of Iron: A Matching-Adjusted Indirect Comparison of Data from Japanese Randomized Controlled TrialsSeiji Fukumoto, Tatsunori Murata, Yutaka Osuga, et al.Advances in Therapy|August 12, 2023
Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine TumoursJens Otto L Jørgensen, Wouter W de Herder, Wendy A Martin, et al.Advances in Therapy|August 12, 2023
Real-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based ChemotherapyHidetoshi Hayashi, Makoto Nishio, Michiko Takahashi, et al.Advances in Therapy|August 16, 2023
Clinical Performance of New Enhanced Monofocal Intraocular Lenses: Comparison of Hydrophobic C-loop and Hydrophilic Plate-Haptic PlatformAndreas F Borkenstein, Eva-Maria BorkensteinAdvances in Therapy|August 19, 2023
Post-infusion Costs Associated with Idecabtagene Vicleucel Treatment for Patients with Relapsed/Refractory Multiple Myeloma in the KarMMa TrialNovember McGarvey, Brian Ung, Thomas Carattini, et al.Advances in Therapy|July 31, 2023
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical ProgramMichael Chiorean, Marco Daperno, Charlie W Lees, et al.Advances in Therapy|October 16, 2023
Importance of Regular Examination and Follow-up in Pediatric Patients with Neurogenic Bladder: 24-Month Follow-up Study Using a Japanese Health Insurance DatabaseNaoko Izumi, Takeya Kitta, Takahiko MitsuiAdvances in Therapy|October 19, 2023
A Novel Method for Deriving Adverse Event Prevalence in Randomized Controlled Trials: Potential for Improved Understanding of Benefit-Risk Ratio and Application to Drug LabelsDaria Piacentino, Ajay Ogirala, Robert Lew, et al.Advances in Therapy|October 11, 2023
Development of a Conceptual Model for the Patient Experience of Focal Segmental Glomerulosclerosis (FSGS): A Qualitative Targeted Literature ReviewNatalie V J Aldhouse, Helen Kitchen, Tamara Al-Zubeidi, et al.Pageof 451